A El-Osta
Overview
Explore the profile of A El-Osta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
1184
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Watt K, Henstridge D, Ziemann M, Sim C, Montgomery M, Samocha-Bonet D, et al.
Nat Commun
. 2021 May;
12(1):2887.
PMID: 34001905
Obesity is a major risk factor underlying the development of metabolic disease and a growing public health concern globally. Strategies to promote skeletal muscle metabolism can be effective to limit...
2.
Harris M, Kreindler J, El-Osta A, Esko T, Majeed A
J R Soc Med
. 2021 Apr;
114(6):290-294.
PMID: 33870766
No abstract available.
3.
Shi Z, Tuomilehto J, Kronfeld-Schor N, Alberti G, Stern N, El-Osta A, et al.
J Intern Med
. 2020 Dec;
289(6):851-860.
PMID: 33340184
Background: To compare the predictive value of the circadian syndrome (CircS) and Metabolic syndrome (MetS) for cardiovascular disease. Method: We used the data of 9360 Chinese adults aged ≥40 years...
4.
Wang C, Bakhet M, Roberts D, Gnani S, El-Osta A
Public Health
. 2020 Sep;
186:286-296.
PMID: 32882481
Objective: To determine the effectiveness of microlearning in improving an individual's capability for self-care. Study Design: Systematic review of the literature. Background: The routine adoption of health seeking self-care behaviours...
5.
Zimmet P, Alberti K, Stern N, Bilu C, El-Osta A, Einat H, et al.
J Intern Med
. 2019 May;
286(2):181-191.
PMID: 31081577
The Metabolic Syndrome is a cluster of cardio-metabolic risk factors and comorbidities conveying high risk of both cardiovascular disease and type 2 diabetes. It is responsible for huge socio-economic costs...
6.
Khurana I, Kaspi A, Ziemann M, Block T, Connor T, Spolding B, et al.
Int J Obes (Lond)
. 2016 Apr;
40(7):1079-88.
PMID: 27108813
Background/objective: The rising incidence of obesity is a major public health issue worldwide. Recent human and animal studies suggest that parental diet can influence fetal development and is implicated with...
7.
Keating S, El-Osta A
Clin Genet
. 2013 Feb;
84(1):1-10.
PMID: 23398084
Diabetes is a multifactorial disease with numerous pathways influencing its progression and recent observations suggest that the complexity of the disease cannot be entirely accounted for by genetic predisposition. A...
8.
Licciardi P, Ververis K, Tang M, El-Osta A, Karagiannis T
Curr Mol Med
. 2012 Oct;
13(4):640-7.
PMID: 23061676
Histone deacetylase inhibitors (HDACi) have emerged as a new generation of anticancer therapeutics. The classical broad-spectrum HDACi typically alter the cell cycle distribution and induce cell death, apoptosis and differentiation...
9.
Demars J, Le Bouc Y, El-Osta A, Gicquel C
Curr Med Chem
. 2011 Apr;
18(12):1740-50.
PMID: 21466477
Fetal growth is a complex process depending on the genetics of the fetus, the availability of nutrients to the fetus, maternal nutrition and various growth factors and hormones of maternal,...
10.
Mah L, El-Osta A, Karagiannis T
Leukemia
. 2010 Feb;
24(4):679-86.
PMID: 20130602
Phosphorylation of the Ser-139 residue of the histone variant H2AX, forming gammaH2AX, is an early cellular response to the induction of DNA double-strand breaks. Detection of this phosphorylation event has...